Braskem is trading at BRL 4.67, up 6.62% on October 9, with no reported catalyst explicitly linked to the gain. - The restructuring process reaches an October 9 milestone. - Recent coverage described creditor resistance to proposals involving roughly $11 billion of debt; no agreement or resolution is confirmed today. - The supplied broad U.S. market gains are modest and do not establish a market-wide explanation for Braskemβs move.